UroGen Pharma Ltd. — Investor Relations & Filings
UroGen Pharma Ltd. is a biopharmaceutical company focused on developing and commercializing treatments for urothelial and specialty cancers. The company aims to transform the treatment paradigm in uro-oncology by providing novel therapeutic options. Its approach is centered on the proprietary RTGel™ reverse-thermal hydrogel technology, which enables sustained local delivery of therapies. The company's commercial product, ZUSDURI™, is a treatment for recurrent Low-Grade, Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC). UroGen's clinical pipeline includes investigational candidates such as UGN-103, also being developed for LG-IR-NMIBC, as part of its commitment to advancing therapies for urologic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 | 2025-12-01 | English | |
| FORM 4 | 2025-12-01 | English | |
| FORM 4 | 2025-11-20 | English | |
| Regulatory Filings 2025 | 2025-11-19 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12942228 | FORM 4 | 2025-12-01 | English | ||
| 12942229 | FORM 4 | 2025-12-01 | English | ||
| 12942230 | FORM 4 | 2025-11-20 | English | ||
| 12942231 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 12942232 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12942233 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12942234 | S-8 | 2025-11-06 | English | ||
| 12942235 | S-3ASR | 2025-11-06 | English | ||
| 12942236 | FORM 10-Q | 2025-11-06 | English | ||
| 12942237 | FORM 8-K | 2025-11-06 | English | ||
| 12942238 | FORM 4 | 2025-10-09 | English | ||
| 12942239 | FORM 4 | 2025-09-09 | English | ||
| 12942240 | FORM 4 | 2025-09-09 | English | ||
| 12942241 | Regulatory Filings 2025 | 2025-09-09 | English | ||
| 12942243 | Regulatory Filings 2025 | 2025-09-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
UroGen Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for UroGen Pharma Ltd. (id: 32312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.